123 related articles for article (PubMed ID: 3127851)
1. Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.
Dencker SJ; Johansson R; Malm U
Psychopharmacology (Berl); 1988; 94(2):237-41. PubMed ID: 3127851
[TBL] [Abstract][Full Text] [Related]
2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Wiles DH; McCreadie RG; Whitehead A
Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
[TBL] [Abstract][Full Text] [Related]
4. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Turbott J; Villiger J; Hunter L
Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
[TBL] [Abstract][Full Text] [Related]
5. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Brown WA; Silver MA
J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of fluphenazine and prolactin in psychiatric patients.
Kitamura T; McGovern DA; Imlah NW; Wiles D; Schiff AA
Eur Arch Psychiatry Neurol Sci; 1988 Sep; 237(6):320-6. PubMed ID: 3181218
[TBL] [Abstract][Full Text] [Related]
7. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
8. The effect of fluphenazine on basal prolactin concentrations.
Chalmers RJ; Bennie EH
Psychol Med; 1978 Aug; 8(3):483-6. PubMed ID: 704714
[TBL] [Abstract][Full Text] [Related]
9. The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.
Glazer WM; Friedhoff LT; Marder SR; Brown WA
Schizophr Res; 1992 Dec; 8(2):111-7. PubMed ID: 1457388
[TBL] [Abstract][Full Text] [Related]
10. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
[TBL] [Abstract][Full Text] [Related]
11. Depot fluphenazine and plasma prolactin.
Gift T; Plum K; Price M
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):407-12. PubMed ID: 4070643
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
13. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710
[TBL] [Abstract][Full Text] [Related]
14. Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression.
Gitlin MJ; Nuechterlein KH; Mintz J; Fogelson D; Bartzokis G; Ventura J; Subotnik K; Aravagiri M
Psychopharmacology (Berl); 2000 Mar; 148(4):350-4. PubMed ID: 10928306
[TBL] [Abstract][Full Text] [Related]
15. Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Altamura AC; Curry SH; Montgomery S; Wiles DH
Psychopharmacology (Berl); 1985; 87(1):30-3. PubMed ID: 3933035
[TBL] [Abstract][Full Text] [Related]
16. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
Fünfgeld EW; Kulhanek F
Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
[TBL] [Abstract][Full Text] [Related]
18. [The plasma prolactin level under fluphenazine treatment (author's transl)].
Hinterhuber H; Platz T; Schwarz S
Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
[TBL] [Abstract][Full Text] [Related]
19. Fluphenazine activity and antipsychotic response.
Hitzemann RJ; Garver DL; Mavroidis M; Hirschowitz J; Zemlan FP
Psychopharmacology (Berl); 1986; 90(2):270-3. PubMed ID: 3097710
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
Viala A; Ba B; Durand A; Gouezo F; Hou N; Jørgensen A
Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
